Showing results (1631-1640 of 2,117) with videos related to
Sort By:
Pageof 212
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 18, 2015
Quality assurance in melanoma surgery: The evolving experience at a large tertiary referral centreR L Read, S Pasquali, L Haydu, et al.Journal of Medical Economics|October 28, 2014
Cost-effectiveness analysis of neoadjuvant pertuzumab and trastuzumab therapy for locally advanced, inflammatory, or early HER2-positive breast cancer in CanadaC L Attard, A N Pepper, S T Brown, et al.Journal of the American Academy of Dermatology|November 5, 2019
The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort studyNorbertus A Ipenburg, Serigne N Lo, Ricardo E Vilain, et al.Annals of Surgical Oncology|June 11, 2014
Primary melanoma location on the scalp is an important risk factor for brain metastasis: a study of 1,687 patients with cutaneous head and neck melanomasAnna M Huismans, Lauren E Haydu, Kerwin F Shannon, et al.Lab on a Chip|April 6, 2016
Development of radiodetection systems towards miniaturised quality control of PET and SPECT radiopharmaceuticalsMatthew P Taggart, Mark D Tarn, Mohammad M N Esfahani, et al.Neoplasia (New York, N.Y.)|October 28, 2008
p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumorsStuart J Gallagher, John F Thompson, James Indsto, et al.ANZ Journal of Surgery|November 1, 2019
Current management of patients with melanoma who are found to be sentinel node-positiveAmanda A G Nijhuis, Andrew J Spillane, Jonathan R Stretch, et al.American Journal of Human Genetics|January 1, 1995
Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndromeB C Broughton, A F Thompson, S A Harcourt, et al.Pigment Cell & Melanoma Research|April 6, 2013
Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progressionGeorgina V Long, James S Wilmott, Lauren E Haydu, et al.Pageof 212